Page last updated: 2024-08-22

stanozolol and Coronary Disease

stanozolol has been researched along with Coronary Disease in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19907 (87.50)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kühlkamp, V; Mewis, C; Seipel, L; Spyridopoulos, I1
Conkie, JA; Davidson, JF; Walker, ID; Young, P1
Bondarenko, IP1
Bielawiec, M; Bodzenta, A; Czestochowska, E; Dabrowski, S; Kiersnowska-Rogowska, B; Kłoczko, J; Lukjan, H; Myśliwiec, M; Tymiński, W1
Davidson, JF; Lochhead, M; McDonald, GA; McNicol, GP1
Davidson, JF; McDonald, GA; McNicol, GP1
Bielawiec, M; Myśliwiec, M; Perzanowski, A1
Conkie, JA; Davidson, JF; McDonald, GA1

Trials

5 trial(s) available for stanozolol and Coronary Disease

ArticleYear
Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels.
    Thrombosis et diathesis haemorrhagica, 1975, Sep-30, Volume: 34, Issue:1

    Topics: Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Anabolic Agents; Antithrombins; Clinical Trials as Topic; Coronary Disease; Disseminated Intravascular Coagulation; Ethylestrenol; Fibrinolysis; Humans; Male; Methandriol; Methandrostenolone; Methenolone; Middle Aged; Norethandrolone; Oxymetholone; Stanozolol

1975
[Effect of anabolic steroids on liver function in severe forms of chronic circulatory insufficiency].
    Vrachebnoe delo, 1979, Issue:5

    Topics: Anabolic Agents; Benzothiadiazines; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Diuretics; Drug Evaluation; Humans; Liver; Liver Function Tests; Methandrostenolone; Sodium Chloride Symporter Inhibitors; Stanozolol; Strophanthins

1979
Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Folia haematologica (Leipzig, Germany : 1928), 1986, Volume: 113, Issue:1-2

    Topics: Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Coronary Disease; Female; Fibrinolysis; Humans; Male; Methandrostenolone; Middle Aged; Myocardial Infarction; Phenformin; Stanozolol; Thrombophlebitis; Varicose Veins

1986
Fibrinolytic enhancement by stanozolol: a double blind trial.
    British journal of haematology, 1972, Volume: 22, Issue:5

    Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Stanozolol

1972
Fibrinolytic enhancement by stanozolol: a double-blind trial.
    Journal of clinical pathology, 1972, Volume: 25, Issue:7

    Topics: Clinical Trials as Topic; Coronary Disease; Fibrinolysis; Humans; Phenformin; Placebos; Stanozolol

1972

Other Studies

3 other study(ies) available for stanozolol and Coronary Disease

ArticleYear
Manifestation of severe coronary heart disease after anabolic drug abuse.
    Clinical cardiology, 1996, Volume: 19, Issue:2

    Topics: Adult; Anabolic Agents; Coronary Disease; Humans; Male; Myocardial Infarction; Stanozolol; Substance-Related Disorders; Tachycardia, Ventricular

1996
The influence of some drugs on platelet aggregation and adhesion.
    Acta Universitatis Carolinae. Medica. Monographia, 1972, Volume: 53

    Topics: Administration, Oral; Adult; Aged; Arteriosclerosis Obliterans; Coronary Disease; Densitometry; Drug Therapy, Combination; Esters; Female; Fibrinolysis; Humans; Male; Middle Aged; Nicotinic Acids; Phenformin; Platelet Adhesiveness; Raynaud Disease; Serum Globulins; Solubility; Stanozolol; Theophylline; Thromboangiitis Obliterans

1972
Fibrinolytic enhancement by stanozolol--a two year study.
    British journal of haematology, 1972, Volume: 22, Issue:5

    Topics: Coronary Disease; Fibrin; Fibrinolysis; Humans; Male; Stanozolol

1972